![]() Bio Products Laboratory Bio Products Laboratory (BPL) is a company that develops and provides plasma-derived protein products. | ![]() APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 1952 | Founding Date 2005 | Founding Date 1909 | Founding Date 1985 | Founding Date 1928 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Borehamwood, GB HQ Durham, US | Locations Wien, AT HQ | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 2,3351% increase | Employees 5 | Employees 23,800 | Employees 9,067 | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 6.7 b | Valuation ($) 4.2 b | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €7.5b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €4.2b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income €500m (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income €1.6b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 110 (H2, 2021) | Countries N/A | Countries 35 (FY, 2019) |

APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
View company
Grifols is a pharmaceutical and chemical manufacturer.
View companyLivzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company